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        Wastewater-based epidemiology (WBE) has been shown to be an innovative approach 12 
for monitoring drug use in communities by quantifying drug residues (so-called “drug 13 
biomarkers”) in sewage1, 2. WBE has thus far been validated by assessing illicit drug use 14 
trends across Europe, with the evaluation of spatial differences and temporal changes in the 15 
levels of specific biomarkers in sewage from 42 cities in 21 European countries (total 16 
population 24.74 million)1. It is hypothesized that sewage contains additional information on 17 
the lifestyle, health and pollutant exposure of a community which could also be obtained by 18 
the analysis of sewage biomarkers2. In fact, feces and urine from either humans or animals 19 
carry many biomarkers and pathogens, which could and enter the sewer system from a carrier 20 
of the disease in the community, e.g. patients at hospitals. Those pathogens such as bacteria, 21 
viruses and parasites in wastewater are hazardous to humans because they might cause 22 
epidemics in population. However, human hazards can be minimized if those pathogens 23 
could be monitored at an early stage in the community. Unlike illicit drug use trends, 24 
infectious diseases require rapid or even real-time detection to assess whether there is a need 25 
for the containment of the disease carriers to certain areas and prevent the development of an 26 
epidemic. To this end, there is a need to develop novel analytical tools that are able to 27 
accurately and rapidly monitor low levels of biomarkers/pathogens with minimal sample 28 
processing by unskilled personnel at the site of sample collection. Emerging biosensing 29 
technology will play a key role in the in situ quantitative analysis of biomarkers and 30 
pathogens in sewage due to rapid response times, low cost, minimal sample processing, high 31 
data resolution and ability to operate remotely. Community sewage sensors employed to 32 
detect biomarkers of health and diseases at a population-level have therefore the clear 33 
potential to provide real-time data for the assessment of community-wide health.   34 
        Biosensors have emerged as powerful tools for the detection of disease biomarkers for 35 
both healthcare and environmental monitoring. A biosensor is a small device with a 36 
biological receptor (DNA, antibody, protein etc.) that generates a signal (electrochemical, 37 
optical, piezoelectric, nanomechanical, mass sensitive etc.) in the presence of an analytical 38 
target (analyte). Compared to conventional analytical tools, biosensors can provide rapid 39 
response times, ultra-sensitive detection of biomolecules, and the potential to be miniaturized 40 
for portable assays requiring minimal sample processing. Moreover, this approach could be 41 
employed, not only for the detection of pathogens, but also for the monitoring of more 42 
general public health indicators such as obesity, diabetes, high blood pressure and sexually 43 
transmitted infections. For example, a recent report demonstrates that the level of an 44 
American city’s obesity could be predicted by analyzing the bacterial community structure 45 
found in sewage3. Such an approach providing near real-time and continuous data would 46 
serve as an early warning sensing system to help agencies, such as the “Centre for Disease 47 
Control and Prevention” (CDC) in the United States, to make effective interventions to 48 
prevent the spread of epidemics, evaluate the effects of interventions and in turn increase the 49 
effectiveness of their policies and use of valuable resources. For example, in 2003 the 50 
effective interventions of CDC in the United States helped reduced spread of severe acute 51 
respiratory syndrome (SARS) to a minimum level.  52 
        A large number of biosensors have been developed for the detection of disease 53 
biomarkers and pathogens in samples such as urine, sera and saliva (Table 1). Although 54 
sewage is a complex matrix, spurious effects, such as nonspecific interactions can be 55 
minimized provided that an ultra-high affinity probe such as an aptamer is used to target 56 
specific analytes, as well as by calculating the differential response of a probe and a reference 57 
chip. As an example, a macrocantilever-based label-free biosensor can quantitatively detect a 58 
prostate cancer biomarker (α-methylacyl-CoA racemase; AMACR) directly in patients’ urine 59 
without any sample preparation4. Hence, there is the clear potential to develop a wider range 60 
of innovative community sensors to quantitatively assess sewage profiles and patterns of 61 
factors related to health and illness within populations using WBE. Additionally, biosensors 62 
have the potential to be miniaturized to a handheld device for point-of-care analysis that may 63 
facilitate the monitoring of infectious diseases in developing countries where the occurring 64 
rate (such as malaria, acquired immune deficiency syndrome (AIDS) and tuberculosis) is 65 
extremely high. For instance, a plasmonic enzyme-linked immunosorbent assay (ELISA) has 66 
been developed to ultra-sensitively detect an HIV-1 capsid antigen p24 at concentrations as 67 
low as 1 attogram per millilitre in serum of HIV-infected patients with the naked eye5. In this 68 
sensor, the ELISA enzyme controls the aggregation of nanoparticles, rising a blue colour if a 69 
target protein is present otherwise a red colour if no target. All of these biosensors can 70 
potentially be used in sewage matrices as community sensors to assess urinary and fecal 71 
biomarkers/pathogens for the monitoring of public health using WBE, while also providing a 72 
means of collecting data for epidemiological and socio-economic studies. Community 73 
sewage sensors arrays can be customized designed for the monitoring of different 74 
biomarkers/pathogens in a single assay. Their use could be of considerable economic and 75 
societal impact especially in resource-constrained areas. More importantly, biosensing 76 
technology platforms can be utilized to collect information on community-wide health in 77 
order to report to health agencies as an early prevention measurement and effective 78 
interventions. Although the selectivity and long-term stability of community sensors as well 79 
as environmental susceptibility to deterioration of bio-recognition are yet to be addressed, we 80 
envisage that the rapid and real-time monitoring of health in communities will soon be 81 
possible.  82 
Table 1 Examples of biosensors used for the detection of infectious diseases and pathogens  83 
Infectious 
diseases 
Biosensors and its transducers Biomarkers/pathogens 
HIV Plasmonic ELISA  protein biomarkers 
 Impedimetric, voltammetric and 
amperometric proteins biosensors 
HIV virus lysate, HIV-1 protease 
 Mechanical sensors  HIV CD4 T cell number 
Tuberculosis  Electrochemical PCR-free mycobacterium 
tuberculosis (MTB) genomic sensors 
PCR-free MTB nucleic acid or cells  
Others 
diseases 
Fluorescent peptides sensors Drug resistant chronic myelogenous 
leukemia 
Pathogens Fluorescent array, evanescent wave fibre-
optic, laser cytometry, electrochemical and 
mass sensitive DNA/antibodies sensors 
Pathogenic Bacillus species like 
Bacillus anthracis and bacillus cereus 
 Optical, electrochemical and mass sensitive 
DNA/ aptamers/antibodies  biosensors 
campylobacter species for 
campylobacteriosis 
 Fluorescent, electrochemical and 
piezoelectric antibody/lectin/ganglioside 
biosensors 
cholera toxin from bacterium Vibrio 
cholera 
 Optical, electrochemical, mass sensitive 
antibodies/antimicrobial 
peptides/aptamers/bacteriophages 
biosensors 
Escherichia coli, like E coli O157:H7; 
Listeria moncytogenes,; Salmonella; 
Shigella spp, Staphylococcus aureus; 
viral threats (smallpox viral 
hemorrhagic fevers, viral encephalitis 
etc.) 
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